Medical Writer
Cycle Pharmaceuticals
Medical Writer
Cycle Pharmaceuticals
Repurposes drugs for rare diseases
Medical Writer
Cycle Company: Cycle Pharmaceuticals Ltd
Position Summary: This full-time position is within the Research and Development department in our Cambridge office on a hybrid basis (minimum 3 days in the office).
At Cycle Pharma, we’re looking for an experienced medical writer to lead the development of clinical and regulatory documents across our late-stage and post-approval programmes, helping bring important treatments to patients with rare and complex diseases.
You’ll take ownership of key documents across the clinical development journey, from Phase 3 study protocols and clinical study reports through to marketing applications, as well as Phase 4 and post-approval studies supporting our marketed products. Combining hands-on authoring with oversight of external writing partners, you’ll play a pivotal role in ensuring our submissions are scientifically robust, clearly communicated and consistently delivered to the highest standards.
Working across programmes in metabolic disease, neurology, immunology and oncology, you’ll collaborate closely with Clinical Development, Regulatory Affairs, Clinical Operations, Pharmacovigilance and Medical Affairs. You’ll bring complex clinical data and regulatory requirements together into clear, accurate and compelling documents that support sound decision-making and successful regulatory submissions.
If you’re a detail-oriented medical writer who combines scientific expertise with excellent communication skills, enjoys collaborating across multidisciplinary teams and wants to make a meaningful contribution to the development of treatments for patients with significant unmet medical needs, we’d love to hear from you.
Our Company
At Cycle, we believe that Every Single Patient Matters. This is at the heart of why we work and were looking for people to join our team who share our vision. We know that life-changing treatments need life-improving product support to match, because when you put the two together, great things can happen.
Our growing portfolio now covers oncology, haematology, neurology and rare metabolic genetic conditions where we improve existing drugs, repurpose them for new uses and bring generics back to market. Using cutting-edge drug delivery technologies, we enhance the efficiency of treatments, offering patients greater freedom and choice.
Headquartered in Cambridge, UK, with a significant US presence, Cycle has scaled rapidly and was named one of the UK’s fastest-growing private companies by The Sunday Times (Sunday Times 100 2024 & Sunday Times 100 Tech 2025). If you want to know more about what we do then, why not check out our website and take a look at some of our patient stories: Patient Stories - Cycle Pharma
What you’ll be doing in this role:
The following skills and experience will be important in helping to set you up to succeed in this role:
What can we offer to you:
In addition to being part of a great team and doing things that will make a real difference to patients’ lives, you will enjoy all the benefits that brings:
Diversity and Inclusion statement:
At Cycle Pharmaceuticals, we are committed to creating an inclusive, respectful, positive and diverse workplace. We do not discriminate on the basis of race, colour, religion, gender, age, disability, or any other protected characteristic. We actively support and embrace diversity, and we are working to build a team that reflects a wide range of backgrounds and perspectives.
We value your unique contributions and encourage you to join us in shaping a more inclusive future. If you require any reasonable adjustments - whether during the application process or in the workplace - we will be happy to support your needs. At Cycle, equality, inclusion, and respect are at the core of everything we do. We fully comply with all applicable employment laws, including those related to non-discrimination, work authorization, and employment eligibility verification.
Repurposes drugs for rare diseases
Cycle Pharmaceuticals develops and sells medicines that improve existing drugs for rare genetic diseases. It focuses on repurposing, reformulating, and reintroducing generic medications to treat rare metabolic, immunological, and neurological conditions (such as HT-1, PKU, MS). Its products are delivered as ready-to-use therapies in the United States, aided by the Cycle Vita patient support program that helps with education, insurance coordination, and affordability to ensure patients can stay on treatment. Unlike some peers that chase new molecular entities, Cycle builds value by optimizing existing drugs to fit patient needs, aiming for reliable cash flow, profitability, and the ability to fund acquisitions and growth. The company also operates a social mission to provide free medicines in developing countries. Overall, its goal is to improve quality of life for people with rare diseases while expanding access and maintaining sustainable operations.
Explore more opportunities at Cycle Pharmaceuticals